<DOC>
	<DOC>NCT00396214</DOC>
	<brief_summary>The primary objective of the study is to evaluate changes in weight short and long term with bifeprunox and quetiapine. Study participation for the subject is 57 weeks.</brief_summary>
	<brief_title>Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Body Weight Changes</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Diagnosis of Schizophrenia 1865 years No hospitalization for an exacerbation of schizophrenia within two months prior to screening and during the screening period Subjects who are acutely psychotic or subjects with current Axis I primary psychiatric diagnosis other than schizophrenia At significant risk of suicide, and the potential for violent behavior (likely to harm themselves or others) based on history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>weight changes</keyword>
</DOC>